Refine by
Radiotherapy System Articles & Analysis: This-Year
1 news found
RTsafe is proud to announce that its core innovation, the PseudoPatient®, has received official Medical Device Marketing Authorization (MDMA-2-2026-0352) from the Saudi Food & Drug Authority (SFDA). This important regulatory milestone enables RTsafe to market and distribute PseudoPatient across the Kingdom of Saudi Arabia and represents a significant step forward in the company’s ...
ByRTsafe
